Mergers and Acquisitions

Date: 2016-05-31

Type of information: Company acquisition

Acquired company: Italchimici (Italy)

Acquiring company: Recordati (Italy)

Amount: € 130 million

Terms:

• • On May 31, 2016, Recordati announces the acquisition of 100% of the share capital of Italchimici, an Italian pharmaceutical company with operational headquarters in Milan, from Progressio SGR, manager of the fund Progressio Investimenti II, IDeA Capital Funds SGR, manager of the fund Fondo IDeA Efficienza Energetica e Sviluppo Sostenibile, and from managers of the company itself. The value of the transaction (enterprise value) is of around € 130 million and will be funded from existing liquidity. The signing and closing of the transaction took place at the same time.

Details: Italchimici, with over 40 years of history and revenues in 2015 of € 46 million, is a consolidated firm that offers therapeutical solutions mainly in the gastroenterological and respiratory areas which consist of both pharmaceutical products as well as food supplements and medical devices to improve the health and well-being of patients. The main brands in its extensive product portfolio are Reuflor, Peridon and Lacdigest in the gastroenterological offering and Aircort among the respiratory products.

Related: Gastrointestinal diseases - Respiratory diseases

Is general: Yes